Alteration of Cellular Reduction Potential Will Change (64)Cu-ATSM Signal With or Without Hypoxia

Therapies targeting reductive/oxidative (redox) metabolism hold potential in cancers resistant to chemotherapy and radiation. A redox imaging marker would help identify cancers susceptible to redox-directed therapies. Copper(II)-diacetyl-bis(4-methylthiosemicarbazonato) (Cu-ATSM) is a PET tracer dev...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Nucl Med
Main Authors: Floberg, John M., Wang, Lingjue, Bandara, Nilantha, Rashmi, Ramachandran, Mpoy, Cedric, Garbow, Joel R., Rogers, Buck E., Patti, Gary J., Schwarz, Julie K.
Formato: Artigo
Idioma:Inglês
Publicado em: Society of Nuclear Medicine 2020
Assuntos:
Molecular Imaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067520/
https://ncbi.nlm.nih.gov/pubmed/31586008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.230805
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados